HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thinking About Switching? Dr Gauld On The Go-To Markets Today

Executive Summary

In this first installment of an exclusive three-part series, global switch expert Dr Natalie Gauld speaks to HBW Insight about what makes a country an attractive environment for switching and highlights those markets leading the way today. 

Related Content

AESGP Annual Meeting, Day 3: Real-World Evidence, Co-Creating Brands And National Success Stories
German Industry Wants To Simplify 'Complicated' Switch Process
Brexit Could Open Up Rx-To-OTC Switch Opportunities In UK, Says MHRA
OTCs Under Threat In Europe: Calls To Reverse-Switch Codeine And Others In Poland And Ireland
Australian Industry Welcomes Possible Oral Contraceptive Switch
FDA OTC Switch Guidance Omits Some Turns As Approval Roadmap, CHPA Says
Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance
Viagra Connect hits UK shelves


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts